Recombinant 50S ribosomal protein L29 (rpmC)

Shipped with Ice Packs
In Stock

Description

Biotechnological Production

Recombinant rpmC is expressed in multiple systems:

Expression Systems and Yields

SystemTurnaround TimeAdvantages
E. coliShortestCost-effective, high yield (~15–52% increase under simulated microgravity)
YeastModerateEukaryotic folding, moderate yield
Baculovirus/InsectLongestPost-translational modifications
Mammalian CellsLongestHuman-compatible modifications
  • Optimal Conditions: Simulated microgravity (SMG) enhances plasmid copy numbers and protein yields in E. coli by upregulating ribosome assembly genes (e.g., rplO, rpsK) and chaperones (e.g., Trigger factor) .

Ribosomal Interactions

  • rRNA Binding: Associates with 23S rRNA to stabilize the polypeptide exit tunnel’s exterior .

  • Trigger Factor Interaction: Facilitates co-translational folding of nascent polypeptides .

  • Subunit Assembly: Non-essential for growth but critical for efficient 50S-30S subunit joining .

RNA Chaperone Activity

While rpmC itself is not directly implicated, related 50S subunit proteins (e.g., L1, L19) exhibit RNA chaperone activity, resolving misfolded rRNA during translation .

Transcriptomic and Proteomic Insights

Under SMG, recombinant E. coli expressing rpmC shows:

  • Upregulated Pathways:

    • Translation: Ribosomal proteins (+12.4%), RNA polymerase (+4.1%), aminoacyl-tRNA biosynthesis (+2.9%) .

    • Energy Metabolism: Glycolysis, TCA cycle, and ATP-binding cassette transporters .

  • Enhanced Folding: Chaperones (GroEL, DnaK) and protein export systems are upregulated, improving soluble protein yields .

Plasmid Dynamics

  • Copy Number: 1.55- to 2.46-fold increase under SMG vs. normal gravity .

  • Stability: Slight reduction under SMG but offset by higher productivity .

Applications

  • Biochemical Studies: Structural analysis of ribosome assembly and protein-rRNA interactions .

  • Recombinant Protein Production: SMG-optimized E. coli systems leverage rpmC-associated ribosome upregulation for high-yield expression .

  • Drug Target Screening: Mycobacterium tuberculosis homolog Rv0709 (rpmC) is regulated under iron limitation, suggesting therapeutic potential .

Product Specs

Form
Lyophilized powder. We will ship the available format, but you can request a specific format when ordering.
Lead Time
Delivery times vary. Contact your local distributor for details. Proteins are shipped with blue ice packs by default. Request dry ice in advance (extra fees apply).
Notes
Avoid repeated freeze-thaw cycles. Store working aliquots at 4°C for up to one week.
Reconstitution
Briefly centrifuge the vial before opening. Reconstitute in sterile deionized water to 0.1-1.0 mg/mL. Add 5-50% glycerol (final concentration) and aliquot for long-term storage at -20°C/-80°C. Our default final glycerol concentration is 50%.
Shelf Life
Shelf life depends on storage conditions, buffer, temperature, and protein stability. Liquid form: 6 months at -20°C/-80°C. Lyophilized form: 12 months at -20°C/-80°C.
Storage Condition
Store at -20°C/-80°C upon arrival. Aliquot for multiple uses. Avoid repeated freeze-thaw cycles.
Tag Info
Tag type is determined during manufacturing. If you require a specific tag, please let us know and we will prioritize its development.
Buffer Before Lyophilization
Tris/PBS-based buffer, 6% Trehalose.
Datasheet
Please contact us to get it.
Expression Region
2-77
Protein Length
Full Length of Mature Protein
Purity
>85% (SDS-PAGE)
Target Names
rpmC
Target Protein Sequence
AVGVSPGEL RELTDEELAE RLRESKEELF NLRFQMATGQ LNNNRRLRTV RQEIARIYTV LRERELGLAT GPDGKES
Uniprot No.

Q&A

What is 50S ribosomal protein L29 (rpmC) and what are its key functions?

50S ribosomal protein L29 (rpmC) is a component of the bacterial 50S ribosomal subunit that binds 23S rRNA. While it is not essential for bacterial growth, it plays a structural role by surrounding the polypeptide exit tunnel on the outside of the ribosomal subunit. L29 also interacts with trigger factor, suggesting involvement in co-translational protein folding processes .

The protein exists in two different forms within cells: free L29 and L29 bound within the ribosomal complex. This distinction is significant because the free form has been demonstrated to participate in additional cellular functions beyond its structural role in the ribosome . One such function is its involvement in facilitating Tn7 transposition when working together with acyl carrier protein (ACP) .

What is the molecular structure of E. coli 50S ribosomal protein L29 (rpmC)?

E. coli 50S ribosomal protein L29 is a relatively small protein consisting of 63 amino acids with the sequence:
MKAKELREKSVEELNTELLNLLREQFNLRMQAASGQLQQSHLLKQVRRDVARVKTLLNEKAGA

The native protein has a molecular weight of approximately 11.3 kDa in its untagged form . When expressed with common fusion tags for purification purposes, the molecular weight increases accordingly. For example, with an N-terminal 6xHis-tag, it remains close to its native size at 11.3 kDa , while the GST-tagged version has a significantly higher molecular weight of 34.3 kDa due to the large size of the GST fusion partner .

L29 adopts a specific tertiary structure that enables its interaction with 23S rRNA and positioning around the polypeptide exit tunnel, which is crucial for its function within the ribosomal complex.

What expression systems are commonly used for recombinant L29 production?

Recombinant 50S ribosomal protein L29 can be expressed and purified from various host systems, each offering different advantages depending on research needs:

Expression HostAdvantagesConsiderations
E. coliHighest yields, shorter turnaround times, established protocolsLimited post-translational modifications
YeastGood yields, moderate turnaround times, some eukaryotic modificationsMore complex media requirements than E. coli
Insect cells (baculovirus)Many post-translational modifications, good for protein foldingLonger production time, lower yields
Mammalian cellsFull range of post-translational modifications, highest activity retentionLongest production time, typically lowest yields

How can researchers optimize purification protocols for recombinant L29?

Optimizing purification of recombinant L29 requires careful consideration of several factors based on experimental needs. The following methodology has been effectively implemented in published research:

  • Cell Growth Conditions: Grow E. coli cells at 37°C to an OD600 of 0.7-0.8 in LB medium with appropriate antibiotics (e.g., 100 mg/ml carbenicillin for plasmids with amp resistance) .

  • Induction Parameters: Add IPTG to a final concentration of 100 μM and continue growth for approximately 2.5 hours to achieve optimal expression without formation of inclusion bodies .

  • Cell Lysis Buffer Composition: For His-tagged L29, use buffer containing 60 mM imidazole, 20 mM Tris pH 7.9, and 500 mM NaCl. The high salt concentration helps reduce non-specific binding during purification .

  • Alternative Heat Treatment Method: For native L29 purification, researchers have successfully employed heat treatment where the cell extract is boiled while stirring for two minutes, followed by centrifugation at 12,000 g for 15 minutes to remove denatured proteins. This exploits L29's unusual heat stability .

  • Precipitation and Dialysis: After heat treatment, precipitate the remaining proteins with ammonium sulfate at 100% saturation, then dialyze overnight in low-salt buffer (10 mM potassium phosphate pH 7.0, 1 mM EDTA, 5 mM β-ME, 0.1 mM PMSF) .

The final purity should exceed 90% as determined by SDS-PAGE analysis. Store the purified protein in Tris-based buffer with 50% glycerol to maintain stability during long-term storage .

What are the functional differences between free and ribosome-bound L29, and how can researchers study them separately?

The functional dichotomy between free and ribosome-bound L29 represents an important research area. Free L29 has been shown to interact with acyl carrier protein (ACP) to stimulate TnsD binding to attTn7 and enhance Tn7 transposition in vitro, while ribosome-bound L29 maintains its structural role in translation .

Methodological Approach to Study Free vs. Bound L29:

  • Ribosome Fractionation: Separate ribosomal and non-ribosomal fractions using sucrose gradient ultracentrifugation. The free L29 pool will remain in the top fractions, while the bound form will sediment with the 50S subunits and 70S ribosomes.

  • Quantitative Western Blotting: Use specific antibodies against L29 to quantify the relative amounts in each fraction during different growth phases.

  • Genetic Approaches: Similar to studies with ribosomal protein S10 (nusE) in phage λ antitermination, researchers can create conditional mutants where L29 levels can be controlled to determine the threshold concentration needed for its extra-ribosomal functions .

  • In vitro Reconstitution Assays: To test whether 50S subunits containing L29 can influence TnsD binding to attTn7, researchers should purify 50S subunits and test their activity in TnsD binding assays compared to free L29 + ACP .

This multiple approach strategy enables comprehensive investigation of the dual functionality of L29 and helps determine how its distribution between free and bound states affects cellular processes.

How does L29 and ACP interaction modulate Tn7 transposition, and what experimental approaches reveal this relationship?

The interaction between L29 and acyl carrier protein (ACP) represents a fascinating regulatory mechanism for Tn7 transposition, with important methodological considerations for researchers:

L29 and ACP together stimulate the binding of TnsD protein to attTn7 sites more than 20-fold compared to TnsD binding alone . This biochemical collaboration enhances Tn7 transposition in vitro, while mutations in L29 drastically decrease Tn7 transposition in vivo, demonstrating the biological significance of this interaction .

Experimental Approaches to Study This Interaction:

  • Protein Interaction Assays: Electrophoretic mobility shift assays (EMSAs) reveal that L29 causes formation of slower-migrating TnsD-attTn7 complexes, while ACP further enhances this binding .

  • ACP Forms Analysis: Research has identified that ACP exists in two forms that influence TnsD binding: monomeric (ACP)₁ and covalent dimeric (ACP)₂ forms. Both collaborate with L29 to stimulate binding, necessitating careful purification to maintain these distinct forms .

  • Purification Considerations: When studying this interaction, researchers must be aware that:

    • ACP should be purified from an L29- strain (containing a 48-nucleotide deletion within rpmC) to prevent contamination with wild-type L29

    • Since ACP is essential, no ACP null mutants are available, making it impossible to purify L29 in the absence of wild-type ACP, which may complicate interpretation of results

  • Growth Phase Analysis: Evidence suggests that the amount of free L29 available for Tn7 transposition may vary during different cellular growth phases, potentially linking transposition to cellular growth conditions. Researchers should measure L29 availability across the growth curve when studying this phenomenon .

What are the critical factors for successful recombinant L29 expression and how can expression yields be optimized?

Successful expression of recombinant L29 requires careful optimization of several parameters:

  • Vector Selection: For highest yields, use expression vectors with strong, inducible promoters like T7 (pET system). The pET-25b vector has been successfully employed for L29 expression when combined with an E. coli BL21(λ DE3) host strain .

  • Tag Selection and Positioning: N-terminal fusion tags are preferable for L29 expression as demonstrated by successful purification with both 6xHis and GST N-terminal tags . C-terminal tags should be avoided if there are concerns about interfering with the protein's C-terminal functional elements.

  • Expression Temperature: While standard expression typically occurs at 37°C, reducing to 18-25°C after induction can significantly improve solubility for some preparations, particularly when higher molecular weight fusion proteins are used.

  • Induction Parameters: Optimal results have been achieved with induction at OD₆₀₀ between 0.7-0.8 using 100 μM IPTG with continued expression for 2.5 hours . Higher IPTG concentrations or longer induction times may lead to inclusion body formation.

  • Media Composition: Enriched media such as Terrific Broth (TB) or Super Broth can increase biomass and potentially improve yields compared to standard LB medium.

For researchers encountering suboptimal expression, a systematic approach testing combinations of these factors is recommended, with particular attention to temperature and induction timing which often have the most significant impact on yield and solubility.

What methods can researchers use to verify the functional activity of purified recombinant L29?

Verifying the functional activity of purified recombinant L29 requires multiple complementary approaches to assess both its structural integrity and biological function:

  • Structural Integrity Assessment:

    • Circular dichroism (CD) spectroscopy to confirm proper secondary structure

    • Limited proteolysis to verify correct folding (properly folded proteins show characteristic resistant fragments)

    • Thermal shift assays to determine stability and proper folding

  • RNA Binding Activity:

    • Filter binding assays with labeled 23S rRNA fragments to verify the protein's ability to bind its natural target

    • Electrophoretic mobility shift assays (EMSAs) to visualize and quantify L29-RNA complexes

  • Tn7 Transposition Activity Assays:

    • In vitro TnsD binding assays to measure L29's ability to stimulate TnsD binding to attTn7 sites, with and without ACP

    • Quantitative in vitro transposition assays using purified Tn7 transposition proteins (TnsABC+D) to measure the stimulation of transposition by L29

  • Complementation Studies:

    • Express recombinant L29 in L29-deficient strains to verify functionality by measuring growth rates and ribosome assembly

    • Assessing the ability of recombinant L29 to rescue Tn7 transposition defects in L29 mutant strains

These activity assays should be performed with appropriate controls, including wild-type L29 as a positive control and buffer-only or inactive mutant L29 as negative controls.

How can researchers design experiments to investigate L29's dual functionality in ribosome structure and transposition regulation?

Investigating L29's dual functionality requires carefully designed experiments that can distinguish between its roles in the ribosome and in Tn7 transposition:

  • Mutational Analysis Strategy:

    • Create a panel of L29 point mutations targeting specific regions predicted to be involved in either ribosome interaction or Tn7 transposition

    • Assess each mutant for both ribosomal integration and transposition activity to identify separable functional domains

    • Focus on mutations that selectively affect one function while preserving the other

  • Domain Mapping Approach:

    • Generate truncated versions of L29 to identify minimal domains required for each function

    • Use peptide competition assays with synthetic peptides corresponding to different L29 regions to identify which regions are critical for interaction with ACP versus ribosomal components

  • Temporal Regulation Studies:

    • Implement a growth phase analysis tracking the distribution of L29 between ribosomal and free pools across the bacterial growth curve

    • Correlate changes in L29 distribution with Tn7 transposition activity to test the hypothesis that L29 availability modulates transposition in a growth-dependent manner

  • Interaction Network Analysis:

    • Perform pull-down assays followed by mass spectrometry to identify all proteins interacting with L29 under different growth conditions

    • Use proximity labeling techniques (BioID or APEX) with L29 as bait to capture transient interactions in living cells

    • Reconstruct the full interaction network to understand how L29 participates in different cellular processes

  • Quantitative Binding Studies:

    • Determine binding affinities of L29 for different partners (23S rRNA, ACP, TnsD) using surface plasmon resonance or isothermal titration calorimetry

    • Compare these affinities to cellular concentrations of each component to develop a quantitative model of L29 partitioning

These methodological approaches provide a framework for systematically dissecting the dual functionality of L29 and understanding how it may serve as a molecular link between translation and transposition.

How should researchers analyze conflicting data regarding L29's interaction partners and regulatory roles?

When confronted with conflicting data regarding L29's interactions and regulatory functions, researchers should implement a systematic analytical approach:

  • Context-Dependent Analysis: Consider whether discrepancies arise from different experimental conditions. The dual functionality of L29 means its behavior may differ significantly between in vitro reconstituted systems and in vivo environments, or between different growth phases .

  • Concentration-Dependent Effects: Analyze whether conflicting results stem from different L29 concentrations used across studies. The ratio of L29 to its interaction partners (ACP, TnsD, ribosomes) can significantly influence binding kinetics and functional outcomes.

  • Tag Interference Assessment: Compare studies using differently tagged L29 versions. The substantial difference in size between GST-tagged (34.3 kDa) and His-tagged (11.3 kDa) L29 could affect interaction dynamics and lead to apparently conflicting results.

  • Growth Phase Standardization: Normalize data to growth phase when comparing across studies. Since the availability of free L29 may vary throughout the bacterial growth cycle, this could explain contradictory findings from samples harvested at different growth stages .

  • Strain-Specific Variables: Consider genetic background differences between E. coli strains used in different studies. Secondary mutations or strain-specific variations in ACP or other factors could influence L29's behavior.

  • Post-Translational Modification Analysis: Investigate whether post-translational modifications of L29 might explain functional differences, especially when comparing proteins expressed in different host systems .

  • Statistical Validation Framework: Apply rigorous statistical analysis to determine whether apparent conflicts are statistically significant or within the normal range of experimental variation.

By systematically addressing these factors, researchers can often reconcile seemingly contradictory data and develop a more nuanced understanding of L29's multiple roles in bacterial physiology.

What computational approaches can help predict L29's potential interaction sites and regulatory mechanisms?

Several computational approaches can provide valuable insights into L29's interaction interfaces and regulatory mechanisms:

  • Structural Modeling and Docking:

    • Generate homology models of E. coli L29 based on existing ribosomal structures

    • Perform protein-protein docking simulations between L29 and its known partners (ACP, TnsD)

    • Identify potential interaction interfaces through binding energy calculations

  • Molecular Dynamics Simulations:

    • Run molecular dynamics simulations of L29 in free versus ribosome-bound states

    • Analyze conformational changes that might explain differential binding properties

    • Identify flexible regions that could adopt different conformations when interacting with different partners

  • Sequence Conservation Analysis:

    • Perform phylogenetic analysis of L29 across bacterial species

    • Identify highly conserved residues likely to be functionally important

    • Correlate conservation patterns with the presence of Tn7-like elements to identify co-evolution

  • Binding Site Prediction:

    • Use algorithms like COACH, COFACTOR, or FTSite to predict potential binding sites on L29's surface

    • Apply electrostatic surface potential mapping to identify regions likely to interact with RNA versus proteins

  • Network Analysis:

    • Construct protein-protein interaction networks incorporating L29 and its partners

    • Identify potential regulatory hubs that might influence L29's participation in different cellular processes

    • Predict additional interaction partners based on network topology

  • Machine Learning Approaches:

    • Train machine learning models on known ribosomal protein moonlighting functions

    • Use these models to predict additional potential non-ribosomal functions of L29

These computational methods should be used to generate testable hypotheses that can then be validated through targeted experimental approaches, creating an iterative cycle of prediction and verification.

What are promising research avenues for understanding L29's role in coordinating ribosomal function and transposition activity?

Several promising research directions could significantly advance our understanding of L29's dual functionality:

  • Structural Biology Approaches:

    • Determine high-resolution structures of L29 in complex with ACP and TnsD to understand the molecular basis of their interaction

    • Compare these structures with L29 in the ribosomal context to identify conformational changes that might regulate its dual functionality

    • Use cryo-electron microscopy to visualize L29-mediated complexes in near-native conditions

  • Growth-Phase Dependent Regulation:

    • Investigate the hypothesis that L29's availability fluctuates with growth phase, potentially linking Tn7 transposition to cellular growth conditions

    • Develop real-time monitoring systems for tracking L29 localization and interaction partners throughout the bacterial growth cycle

    • Correlate changes in L29 distribution with global changes in translation and transposition rates

  • Systems Biology Integration:

    • Construct comprehensive models incorporating L29's roles in both translation and transposition

    • Investigate whether L29 serves as a molecular sensor that coordinates these processes based on cellular state

    • Examine potential feedback mechanisms between ribosome assembly and transposon activity

  • Evolutionary Perspectives:

    • Analyze the co-evolution of L29, ribosomal components, and transposition machinery across bacterial species

    • Investigate whether the dual functionality of L29 represents an adaptive strategy or an evolutionary coincidence

    • Compare L29 sequences from species with and without Tn7-like elements to identify features specifically related to transposition regulation

  • Therapeutic Applications:

    • Explore whether the interaction between L29 and transposition machinery could be targeted to modulate bacterial adaptability or horizontal gene transfer

    • Investigate if L29's role in transposition could be exploited to prevent the spread of antibiotic resistance genes

These research directions highlight the potential significance of L29 as a molecular link between fundamental cellular processes and may reveal new paradigms in bacterial physiology and regulation.

How might new technological advances improve our ability to study L29's multiple cellular roles?

Emerging technologies offer exciting opportunities to advance our understanding of L29's multifunctional nature:

  • Single-Molecule Techniques:

    • Apply single-molecule FRET to directly observe L29's interactions with different partners in real-time

    • Use single-molecule tracking to follow L29's movement between ribosomal and transposition complexes in living cells

    • Implement optical tweezers to measure the strength of L29's interactions with different binding partners

  • Advanced Proteomics Approaches:

    • Use hydrogen-deuterium exchange mass spectrometry (HDX-MS) to map binding interfaces between L29 and its interaction partners

    • Apply crosslinking mass spectrometry (XL-MS) to capture transient interactions in native cellular environments

    • Implement thermal proteome profiling to identify changes in L29's interactome under different cellular conditions

  • CRISPR-Based Technologies:

    • Develop CRISPR interference systems for precise temporal control of L29 expression

    • Use CRISPR-based imaging techniques to visualize L29 localization in real-time

    • Apply CRISPR screening to identify additional factors that influence L29's dual functionality

  • Nanobody Development:

    • Generate state-specific nanobodies that recognize L29 only when bound to specific partners

    • Use these nanobodies as molecular probes to quantify the distribution of L29 between different functional states

    • Develop nanobody-based biosensors to monitor changes in L29's interactions in response to cellular stress

  • Artificial Intelligence Integration:

    • Apply deep learning approaches to predict functional consequences of L29 mutations

    • Use AI to identify patterns in experimental data that might reveal new regulatory mechanisms

    • Develop predictive models of how L29 partitioning affects cellular physiology

  • Microfluidics and Lab-on-a-Chip:

    • Implement microfluidic systems for high-throughput analysis of L29 variants

    • Develop microcompartmentalization techniques to study L29's behavior in confined spaces mimicking cellular microenvironments

These technological advances promise to provide unprecedented insights into the molecular mechanisms underlying L29's multifunctionality and could reveal new principles of bacterial gene regulation.

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2025 TheBiotek. All Rights Reserved.